GLP-1 for Teachers: Using Summer for Health
Summer break is the perfect window to start GLP-1 treatment -- manage side effects at home and return to school feeling transformed.
Teachers pour everything into their students during the school year, often neglecting their own health. Summer break offers a rare opportunity to focus on yourself -- and starting GLP-1 medication in June means navigating the trickiest part of treatment (early titration) from the comfort of home, not a busy classroom.
Why Summer Is Ideal for Starting GLP-1
Summer Advantage
- Manage side effects privately: Nausea, GI issues peak during first 4-8 weeks -- handle them at home
- No bathroom emergencies: GI side effects are challenging when you cannot leave 30 students
- Time for meal prep: Establish protein-first eating habits before school-year chaos
- Exercise routine: Build a consistent workout habit you can maintain during school
- Visible progress: Colleagues notice 10-15 lbs of summer weight loss
- Mental health boost: Start the school year with more energy and confidence
Summer GLP-1 Timeline
Maintaining During the School Year
Once past the titration phase, maintaining GLP-1 treatment during the school year is straightforward. Weekly injections take 30 seconds. Meal prep on Sundays for the week. Keep protein snacks in your desk drawer. Stay hydrated with a water bottle in the classroom. The reduced appetite means less stress about lunch choices and no afternoon energy crashes from heavy meals.
Affordability on a Teacher's Budget
At $99/month for compounded semaglutide or $125/month for tirzepatide through Trimi, treatment costs less than many gym memberships. HSA and FSA funds (common in teacher benefit packages) can cover GLP-1 medications with a prescription. Many teachers find that reduced spending on food, fewer sick days, and decreased need for other medications offset the cost.
Make This Summer Count
Start before summer break and return to school transformed. Semaglutide $99/month. Tirzepatide $125/month.
Get StartedMedical Disclaimer
This article is for informational purposes only. Individual results and side effect timelines vary. GLP-1 medications require physician oversight. Always consult your healthcare provider.
More on GLP-1 lifestyle
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).